Cytta Corp Financials
| CYCA Stock | USD 0.02 0 4.17% |
With this module, you can analyze Cytta financials for your investing period. You should be able to track the changes in Cytta Corp individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Cytta |
Understanding current and past Cytta Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cytta Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Cytta Corp's assets may result in an increase in income on the income statement.
The data published in Cytta Corp's official financial statements typically reflect Cytta Corp's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Cytta Corp's quantitative information. For example, before you start analyzing numbers published by Cytta accountants, it's essential to understand Cytta Corp's liquidity, profitability, and earnings quality within the context of the Health Care Technology space in which it operates.
Please note, the presentation of Cytta Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cytta Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cytta Corp's management manipulating its earnings.
Cytta Corp Stock Summary
Cytta Corp competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, and DiaMedica Therapeutics. Cytta Corp. develops, markets, and distributes various video streaming products and services. Cytta Corp. was incorporated in 2006 and is headquartered in Las Vegas, Nevada. Cytta Corp operates under Communication Equipment classification in the United States and is traded on OTC Exchange.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US12673W4078 |
| Business Address | 5450 West Sahara |
| Sector | Health Care Technology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cytta.com |
| Phone | 702 900 7022 |
| Currency | USD - US Dollar |
Cytta Corp Key Financial Ratios
Cytta Corp's financial ratios allow both analysts and investors to convert raw data from Cytta Corp's financial statements into concise, actionable information that can be used to evaluate the performance of Cytta Corp over time and compare it to other companies across industries.| Return On Equity | -7.68 | |||
| Return On Asset | -2.89 | |||
| Number Of Employees | 13 | |||
| Beta | 0.73 | |||
| Z Score | -6.7 |
Cytta Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cytta Corp's current stock value. Our valuation model uses many indicators to compare Cytta Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cytta Corp competition to find correlations between indicators driving Cytta Corp's intrinsic value. More Info.Cytta Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cytta Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cytta Corp's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Cytta Corp Systematic Risk
Cytta Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cytta Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Cytta Corp correlated with the market. If Beta is less than 0 Cytta Corp generally moves in the opposite direction as compared to the market. If Cytta Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cytta Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cytta Corp is generally in the same direction as the market. If Beta > 1 Cytta Corp moves generally in the same direction as, but more than the movement of the benchmark.
Cytta Corp November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cytta Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cytta Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cytta Corp based on widely used predictive technical indicators. In general, we focus on analyzing Cytta OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cytta Corp's daily price indicators and compare them against related drivers.
| Downside Deviation | 11.73 | |||
| Information Ratio | 0.0164 | |||
| Maximum Drawdown | 54.16 | |||
| Value At Risk | (16.22) | |||
| Potential Upside | 25.0 |
Complementary Tools for Cytta OTC Stock analysis
When running Cytta Corp's price analysis, check to measure Cytta Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytta Corp is operating at the current time. Most of Cytta Corp's value examination focuses on studying past and present price action to predict the probability of Cytta Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytta Corp's price. Additionally, you may evaluate how the addition of Cytta Corp to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |